Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP vs Oral Chemotherapy in HIV-Associated Lymphoma
NCT01775475Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Sep 2016
- Primary completion
- Apr 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of lomustine, etoposide, cyclophosphamide, procarbazine in AIDS-related non-Hodgkin lymphoma (ARL), sponsored by AIDS Malignancy Consortium. Started Sep 2016; status: completed.
02
Drugs
lomustineetoposidecyclophosphamideprocarbazine
03
Conditions
AIDS-related non-Hodgkin lymphoma (ARL)
Beyond the preview
Go deeper on NCT01775475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01775475.